
Phreesia Inc (PHR) Stock Forecast & Price Target
Phreesia Inc (PHR) Analyst Ratings
Bulls say
Phreesia Inc. demonstrated a strong financial performance with total revenue per Accountable Healthcare System Client (AHSC) increasing by 5.6% year-over-year to $26,622, driven by client expansion across its diverse solution offerings. Additionally, patient payment volumes grew to $1.181 billion in Q3 2026, reflecting a robust 9.3% year-over-year increase, which underscores the company's success in both attracting new clients and expanding existing relationships. Furthermore, the upward revision of adjusted EBITDA guidance to a range of $99 million to $101 million, representing 172% year-over-year growth and exceeding consensus estimates, solidifies a positive outlook for the company amid strengthening healthcare utilization trends.
Bears say
Phreesia's financial performance indicates areas of concern, notably with a sequential decline in the take rate from 2.8% to 2.7%, which can adversely affect revenue streams despite stable payment facilitator volumes. While operating expenses decreased year-over-year, the overall revenue for 3Q26 of $120.3 million fell slightly short of expectations, raising concerns about the company's growth trajectory. Additionally, the slight shortfall in client numbers compared to consensus expectations and potential risks associated with another COVID-19 surge could further hinder the company's topline growth in a challenging healthcare environment.
This aggregate rating is based on analysts' research of Phreesia Inc and is not a guaranteed prediction by Public.com or investment advice.
Phreesia Inc (PHR) Analyst Forecast & Price Prediction
Start investing in Phreesia Inc (PHR)
Order type
Buy in
Order amount
Est. shares
0 shares